Clinical economics and sleep disorders

Sleep

Volumn 20, Issue 10, 1997, Pages 829-834

  Crawford, B ^a  

^a Lewin Group   (United States)

Author keywords

Costs; Economics; Sleep disorders

Indexed keywords

ZOPICLONE;

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INSOMNIA; MEDICAL DECISION MAKING; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SLEEP DISORDER;

COSTS AND COST ANALYSIS; HEALTH CARE COSTS; HUMANS; QUALITY OF LIFE; SLEEP DISORDERS;

EID: 0030844162     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. National Commission on Sleep Disorders Research. Wake up America: a national sleep alert. 1993:1.
2. Leger D. The cost of sleep-related accidents: a report for the National Commission on Sleep Disorders Research. Sleep 1994; 17:84-93.
3. Miller M, Hajdukovic R. Relative efficacy of drugs for the treatment of sleepiness in narcolepsy. Sleep 1994;14:218.
4. Rogers AE, Aldrich MS, Caruso CC. Patterns of sleep and wakefulness in treated narcoleptic subjects. Sleep 1994;17:590.
5. Broughton WA, Broughton RJ. Psychosocial impact of narcolepsy. Sleep 1994; Suppl 8:S45-9.
6. Findley L, Weiss W, Jabour ER. Drivers with untreated sleep apnea. A cause of death and serious injury. Arch Intern Med 1991;151:1451-2.
7. Aldrich MS. Automobile accidents in patients with sleep disorders. Sleep 1989;12:487-94.
8. Findley L, Unverzagt M, Suratt P. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis 1988;138:337-40.
9. Mitler MM, Hajdukovic R, Erman M, Koziol JA. Narcolepsy. J Clin Neurophysiol 1990;7:93.
10. Nauert R. The quest for value in health care. J Health Care Finance 1996;22:52-61
11. Jenkins M, ed. The managed care yearbook, 2nd edition. Wall Township, NJ: American Business Publishing, 1994.
12. Souetre EJ, Qing W, Hardens M. Methodological approaches to pharmaco-economics. Fundam Clin Pharmacol 1994;8:101-7.
13. Rittenhouse B. Designing and conducting cost-minimization and cost-effectiveness analyses. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials, 2nd edition. Philadelphia: Lippincott-Raven Publishers, 1996:1093-103.
14. Souetre E, Martin P. Clinical economics and psychiatry. In: Freeman HL, ed. Royal Society of Medicine Services international congress and symposium series, no. 153. Royal Society of Medicine Services Limited, 1991:67-74.
15. Torrance G. Designing and conducting cost-utility analyses. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials, 2nd edition. Philadelphia: Lippincott-Raven Publishers, 1996:1105-11.
16. Johannesson M, Weinstein M. Designing and conducting cost-benefit analyses. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials, 2nd edition. Philadelphia: Lippincott-Raven Publishers, 1996:1093-103.
17. Idzikowski C. Impact of insomnia on health-related quality of life. Pharmacoeconomics 1996; Suppl 1:15-24.
18. Leger D, Quera-Salva M, Philip P. Health-related quality of life in patients with insomnia treated with zopiclone. Pharmacoeconomics 1996; Suppl 1:39-44.
19. Luce B, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 1990;6:57-75.
20. Sennett C. Defining and measuring costs. In: Cost analysis methodology for clinical practice guidelines, pub. no. 95-0001. Rockville: Agency for Health Care Policy and Research, 1995:47-54.
21. Koopmanschap M, Rutten F, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ 1995;14:171-89.
22. Leger D. The cost of sleepiness: a response to comments. Sleep 1995;18:281-4.
23. Webb W. The cost of sleep-related accidents: a reanalysis. Sleep 1995;18:276-80.
24. Chilcott L, Shapiro C. The socioeconomic impact of insomnia: an overview. Pharmacoeconomics 1996; Suppl 1:1-14.
25. Stoller M. Economic effect of insomnia. Clin Ther 1994;16: 873-97.